{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T04:46:16Z","timestamp":1763959576207},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T00:00:00Z","timestamp":1513296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T00:00:00Z","timestamp":1513296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim Care Resp Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study investigated patient perceptions, experiences and management of COPD throughout the SLS COPD study. Follow-up interviews were conducted with 400 patients who completed SLS COPD; a mixed-methods approach was used to collect quantitative and qualitative information. Structured interviews using closed-ended questions were conducted with 360 patients, detailing aspects of background\/lifestyle information and COPD. Extended interviews containing open-ended questions on perceptions of COPD and quality of life (QoL) in addition to the closed-ended questions were completed by 40 further patients. Participants also completed the Adherence Starts with Knowledge-12 (ASK-12) and the COPD and Asthma Sleep Impact Scale (CASIS) questionnaire. Quantitative data were analysed descriptively; qualitative data were analysed using qualitative description. The participants (<jats:italic>n<\/jats:italic>\u2009=\u2009400) were reasonably representative of the SLS COPD population; mean age was 66.2 years. Breathlessness was the most commonly recalled symptom of\/associated with COPD (88.5% of patients) and was the symptom that changed the most (improved, 26.8%\/worsened, 20.9%) throughout the study. Participants\u2019 daily functioning and activities were most affected by symptoms of\/associated with COPD, followed by relationships and psychological issues. 66.5% of participants experienced exacerbations, 60.5% of whom reported self-management as their first treatment strategy (taking antibiotics, resting and\/or corticosteroids). Qualitative analysis revealed COPD symptoms, breathlessness in particular, to have a significant impact on mobility and in turn QoL. In conclusion, breathlessness was cited in these interviews as the COPD symptom with the greatest impact on participants\u2019 daily functioning, activities and self-care. The findings provided significant additional knowledge to the SLS COPD study findings.<\/jats:p>","DOI":"10.1038\/s41533-017-0066-2","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T19:30:10Z","timestamp":1513107010000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred outcomes"],"prefix":"10.1038","volume":"27","author":[{"given":"Lynda","family":"Doward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Svedsater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Whalley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Leather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Lay-Flurrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Bosanquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"key":"66_CR1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2017 report). http:\/\/goldcopd.org\/gold-2017-global-strategy-diagnosis-management-prevention-copd\/ (2017)."},{"key":"66_CR2","doi-asserted-by":"crossref","unstructured":"Svedsater, H. et al. Life impact and treatment preferences of individuals with asthma and chronic obstructive pulmonary disease: results from qualitative interviews and focus groups. Adv. Ther. 34, 1466\u20131481 (2017).","DOI":"10.1007\/s12325-017-0557-0"},{"key":"66_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12931-016-0433-5","volume":"17","author":"DM Halpin","year":"2016","unstructured":"Halpin, D. M., Kerkhof, M., Soriano, J. B., Mikkelsen, H. & Price, D. B. Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy. Respir. Res. \n                           17, 120 (2016).","journal-title":"Respir. Res."},{"key":"66_CR4","doi-asserted-by":"publisher","first-page":"e90145","DOI":"10.1371\/journal.pone.0090145","volume":"9","author":"AL Kruis","year":"2014","unstructured":"Kruis, A. L. et al. Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One \n                           9, e90145 (2014).","journal-title":"PLoS One"},{"key":"66_CR5","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMoa1608033","volume":"375","author":"J Vestbo","year":"2016","unstructured":"Vestbo, J. et al. Effectiveness of fluticasone furoate-vilanterol for COPD in clinical practice. N. Engl. J. Med. \n                           375, 1253\u20131260 (2016).","journal-title":"N. Engl. J. Med."},{"key":"66_CR6","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1345\/aph.1M174","volume":"43","author":"LS Matza","year":"2009","unstructured":"Matza, L. S. et al. Derivation and validation of the ASK-12 adherence barrier survey. Ann. Pharmacother. \n                           43, 1621\u20131630 (2009).","journal-title":"Ann. Pharmacother."},{"key":"66_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1365-2702.2005.01125.x","volume":"14","author":"M Barnett","year":"2005","unstructured":"Barnett, M. Chronic obstructive pulmonary disease: a phenomenological study of patients\u2019 experiences. J. Clin. Nurs. \n                           14, 805\u2013812 (2005).","journal-title":"J. Clin. Nurs."},{"key":"66_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4104\/pcrj.2011.00035","volume":"20","author":"N Sheridan","year":"2011","unstructured":"Sheridan, N. et al. Helplessness, self blame and faith may impact on self management in COPD: a qualitative study. Prim. Care Respir. J. \n                           20, 307\u2013314 (2011).","journal-title":"Prim. Care Respir. J."},{"key":"66_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1183\/09031936.06.00145104","volume":"27","author":"PW Jones","year":"2006","unstructured":"Jones, P. W. & Agusti, A. G. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur. Respir. J. \n                           27, 822\u2013832 (2006).","journal-title":"Eur. Respir. J."},{"key":"66_CR10","doi-asserted-by":"publisher","first-page":"14060","DOI":"10.1038\/npjpcrm.2014.60","volume":"24","author":"L Siebeling","year":"2014","unstructured":"Siebeling, L. et al. Prediction of COPD-specific health-related quality of life in primary care COPD patients: a prospective cohort study. NPJ Prim. Care Respir. Med \n                           24, 14060 (2014).","journal-title":"NPJ Prim. Care Respir. Med"},{"key":"66_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2147\/COPD.S76157","volume":"10","author":"JJ Stephenson","year":"2015","unstructured":"Stephenson, J. J. et al. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease. Int J. Chron. Obstruct Pulmon Dis. \n                           10, 577\u2013586 (2015).","journal-title":"Int J. Chron. Obstruct Pulmon Dis."},{"key":"66_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12931-014-0122-1","volume":"15","author":"M Miravitlles","year":"2014","unstructured":"Miravitlles, M. et al. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respir. Res. \n                           15, 122 (2014).","journal-title":"Respir. Res."},{"key":"66_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3132\/pcrj.2009.00003","volume":"18","author":"NH Chavannes","year":"2009","unstructured":"Chavannes, N. H. et al. Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial. Prim. Care Respir. J. \n                           18, 171\u2013176 (2009).","journal-title":"Prim. Care Respir. J."},{"key":"66_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2466-13-54","volume":"13","author":"N Barnes","year":"2013","unstructured":"Barnes, N., Calverley, P. M., Kaplan, A. & Rabe, K. F. Chronic obstructive pulmonary disease and exacerbations: patient insights from the global hidden depths of COPD survey. BMC Pulm. Med. \n                           13, 54 (2013).","journal-title":"BMC Pulm. Med."},{"key":"66_CR15","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/j.1365-2702.2012.04285.x","volume":"22","author":"A Cooney","year":"2013","unstructured":"Cooney, A. et al. Life with chronic obstructive pulmonary disease: striving for \u2018controlled co-existence\u2019. J. Clin. Nurs. \n                           22, 986\u2013995 (2013).","journal-title":"J. Clin. Nurs."},{"key":"66_CR16","doi-asserted-by":"publisher","first-page":"e011555","DOI":"10.1136\/bmjopen-2016-011555","volume":"6","author":"G Marx","year":"2016","unstructured":"Marx, G. et al. Meaning of living with severe chronic obstructive lung disease: a qualitative study. BMJ Open \n                           6, e011555 (2016).","journal-title":"BMJ Open"},{"key":"66_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-9-52","volume":"9","author":"MA Neergaard","year":"2009","unstructured":"Neergaard, M. A., Olesen, F., Andersen, R. S. & Sondergaard, J. Qualitative description\u2014the poor cousin of health research? BMC Med. Res. Methodol. \n                           9, 52 (2009).","journal-title":"BMC Med. Res. Methodol."},{"key":"66_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G","volume":"23","author":"M Sandelowski","year":"2000","unstructured":"Sandelowski, M. Whatever happened to qualitative description? Res. Nurs. Health \n                           23, 334\u2013340 (2000).","journal-title":"Res. Nurs. Health"},{"key":"66_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12875-017-0582-8","volume":"18","author":"J Laue","year":"2017","unstructured":"Laue, J., Melbye, H. & Ris\u00f8r, M. B. Self-treatment of acute exacerbations of chronic obstructive pulmonary disease requires more than symptom recognition - a qualitative study of COPD patients\u2019 perspectives on self-treatment. BMC Fam. Pract. \n                           18, 8 (2017).","journal-title":"BMC Fam. Pract."},{"key":"66_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/00005650-199804000-00005","volume":"36","author":"L Bessette","year":"1998","unstructured":"Bessette, L. et al. Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome. Med. Care \n                           36, 491\u2013502 (1998).","journal-title":"Med. Care"},{"key":"66_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1183\/09031936.00035909","volume":"37","author":"JK Quint","year":"2011","unstructured":"Quint, J. K. et al. Predictive accuracy of patient-reported exacerbation frequency in COPD. Eur. Respir. J. \n                           37, 501\u2013507 (2011).","journal-title":"Eur. Respir. J."},{"key":"66_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1477-7525-7-98","volume":"7","author":"RF Pokrzywinski","year":"2009","unstructured":"Pokrzywinski, R. F., Meads, D. M., McKenna, S. P., Glendenning, G. A. & Revicki, D. A. Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS). Health Qual. Life Outcomes \n                           7, 98 (2009).","journal-title":"Health Qual. Life Outcomes"}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-017-0066-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-017-0066-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-017-0066-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T01:41:08Z","timestamp":1671759668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-017-0066-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["66"],"URL":"https:\/\/doi.org\/10.1038\/s41533-017-0066-2","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,15]]},"assertion":[{"value":"30 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.D., D.W. and R.C. are employees of RTI Health Solutions, which has received funding from GSK. H.S., D.L. and J.L.-F. are GSK employees and hold GSK shares. N.B. was a chief investigator for the SLS follow-up interviews and received a fee from GSK.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}